A carregar...
Resistance Mechanisms to Taxanes and PARP Inhibitors in Advanced Prostate Cancer
The clinical landscape concerning advanced prostate cancer is rapidly changing and reaching beyond androgen deprivation therapy and androgen receptor targeted therapies. Taxane chemotherapy is a critical tool in the management of advanced prostate cancer. Additionally, novel drug classes such as PAR...
Na minha lista:
| Publicado no: | Curr Opin Endocr Metab Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7111181/ https://ncbi.nlm.nih.gov/pubmed/32258820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coemr.2020.02.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|